Publications

Dasiglucagon

Castle, J., Elander, M.
Long-Term Safety and Tolerability of Dasiglucagon, a Stable-in-Solution Glucagon Analogue
Article, Diabetes Technology & Therapeutics, 2019, 21, 2, 94.

Hövelmann, U., Bysted, B., Mourtizen, U., Macchi, F., Lamers, D., Kronshage, B., Møller, D., Heise, T.
Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analogue
Article, Diabetes Care 2018, 41, 531-537.

Castle, J., Elander, M., O’Halloran
Long-Term Safety and Tolerability of Dasiglucagon, a Stable-in-Solution Analog
Poster, ATTD (Advanced Technologies and Treatements for Diabetes), Vienna, 14-17 February 2018.

Sabrina L. Wendt, Jan K. Møller, Ahmad Haidar, Britta V. Bysted, Carsten B. Knudsen, Henrik Madsen, John B. Jørgensen.
Model of the Glucose-Insulin-Glucagon Dynamics after Subcutaneous Administration of a Glucagon Rescue Bolus in Healthy Humans
Poster, the American Diabetes Association’s (ADA) 76th Scientific Sessions, New Orleans, USA, June 10-14, 2016.

Sabrina Lyngbye Wendt, Carsten Boye Knudsen, John Bagterp Jørgensen, Henrik Madsen, Ahmad Haidar
Modelling the glucose-insulin-glucagon dynamics after subcutaneous administration of native glucagon and a novel glucagon analog in dogs.
Poster, ATTD (Advanced Technologies and Treatments for Diabetes), Milan, 3-6 February 2016.

Sabrina Lyngbye Wendt, Anders Valeur, Henrik Madsen, John Bagterp Jørgensen, Carsten Boye Knudsen
Pharmacokinetics modeling of glucagon and a novel glucagon analog after subcutaneous administration in dogs.
Poster, ATTD (Advanced Technologies and Treatments for Diabetes), Paris, 18-21 February 2015.

Noerregaard, P., Valeur, A., Svendgaard, M., Giehm, L., Macchi, F., Fosgerau, K. and Riber, D.
The novel glucagon analog ZP-GA-1 has superior physicochemical properties while maintaining the pharmacokinetic and pharmacodynamic profile of native glucagon.
Poster, American Diabetes Association’s (ADA) 74th Scientific Sessions, San Francisco, USA, June 13-17, 2014.

Riber, D., Valeur, A., Svendgaard, M., Giehm, L., Macchi, F., Fosgerau, K. and Noerregaard, P.
The novel glucagon analog ZP-GA-1 has superior physicochemical properties while maintaining the pharmacokinetic and pharmacodynamic profile of native glucagon
Abstract, the American Diabetes Association’s (ADA) 74th Scientific Sessions, San Francisco, USA, June 13-17, 2014.